Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension

被引：52
|
作者：
Halank, M [1 ]
Miehlke, S [1 ]
Hoeffken, G [1 ]
Schmeisser, A [1 ]
Schulze, M [1 ]
Strasser, RH [1 ]
机构：
[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med, D-8027 Dresden, Germany
来源：
TRANSPLANTATION | 2004年 / 77卷 / 11期
关键词：
D O I：
10.1097/01.TP.0000122420.86904.89
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1775 / 1776
页数：2
相关论文
共 50 条
  • [21] The future of endothelin-receptor antagonism as treatment for systemic hypertension
    Gabriel Vorobiof
    Burns C. Blaxall
    John D. Bisognano
    [J]. Current Hypertension Reports, 2006, 8 : 35 - 44
  • [22] Endothelin and endothelin receptor antagonism in portopulmonary hypertension
    Neuhofer, W.
    Guelberg, V.
    Gerbes, A. L.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 54 - 61
  • [23] Endothelin-receptor antagonists in pulmonary hypertension
    Dupuis, J
    [J]. LANCET, 2001, 358 (9288): : 1113 - 1114
  • [24] After 30 years, the first endothelin-receptor antagonist (Aprocitentan) is approved for the treatment of arterial hypertension
    Tamargo, Juan
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (05) : 371 - 373
  • [25] Hemodynamic effects of bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension
    Williamson, DJ
    Wallman, LL
    Jones, R
    Keogh, AM
    Scroope, F
    Penny, R
    Weber, C
    Macdonald, PS
    [J]. CIRCULATION, 2000, 102 (04) : 411 - 418
  • [26] Bosentan: a dual endothelin receptor antagonist
    Rubin, LJ
    Roux, S
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (07) : 991 - 1002
  • [27] HYPERTENSION Endothelin-receptor antagonists for treating hypertension
    Weir, Matthew R.
    [J]. NATURE REVIEWS NEPHROLOGY, 2010, 6 (04) : 192 - 194
  • [28] Approaches to therapy for puhnonary hypertension: Role of the endothelin receptor antagonist bosentan
    Avdeev, S. N.
    [J]. TERAPEVTICHESKII ARKHIV, 2015, 87 (09): : 64 - 71
  • [29] Effects of the oral endothelin receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension
    Galie, N
    Hinderliter, AL
    Torbicki, A
    Simonneau, G
    Espinola-Zabaleta, N
    Rocchi, G
    Kurzyna, M
    Kronenberg, A
    Frantz, R
    Sherif, N
    Barst, R
    Dujardin, K
    Channick, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 224A - 224A
  • [30] Endothelin-receptor antagonists for treating hypertension
    Matthew R. Weir
    [J]. Nature Reviews Nephrology, 2010, 6 : 192 - 194
12345